Macrophage Inflammatory Protein 3 beta (CCL19) Human shRNA Plasmid Kit (Locus ID 6363)
CAT#: TR319889
CCL19 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 6,790.00
货期*
2周
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
CCL19 mouse monoclonal antibody, clone OTI2A12 (formerly 2A12)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | Macrophage Inflammatory Protein 3 beta (CCL19) Human shRNA Plasmid Kit (Locus ID 6363) |
Locus ID | 6363 |
UniProt ID | Q99731 |
Synonyms | CKb11; ELC; MIP-3b; MIP3B; SCYA19 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | CCL19 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 6363). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_006274, NM_006274.1, NM_006274.2, BC027968, BC027968.1, NM_006274.3 |
Summary | This antimicrobial gene is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene may play a role in normal lymphocyte recirculation and homing. It also plays an important role in trafficking of T cells in thymus, and in T cell and B cell migration to secondary lymphoid organs. It specifically binds to chemokine receptor CCR7. [provided by RefSeq, Sep 2014] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
CCR7/CCL19 Controls Expression of EDG-1 in T Cells
,Laura A. Shannon, Tiffany M. McBurney, Melissa A. Wells, Megan E. Roth, Psachal A. Calloway, Charles A. Bill, Shamima Islam, and Charlotte M. Vines,
J. Biol. Chem., Apr 2012; 287: 11656 - 11664.
[CCL19]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...